🤔 This week: TSLA Q3 earnings report - is now the right time to buy the EV giant?Explore TSLA Data
34 results
Popular Screeners
Currency in SEK
SE
Overview
Insights
Valuation
Returns
Technical
Financials
Growth
Risk
Custom
Company
Exchange
Sector
Industry
Market Cap
P/E Ratio
PEG Ratio
Last Trade Price
Day Change (%)
Fair Value
Fair Value Upside
Fair Value Label
Analyst Price Target
Analyst Target Upside
Overall Health
StockholmHealthcarePharmaceuticalsSEK 2.51T37x8.79SEK 1,618.50-1%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+-1% DownsideUpgrade to Pro+
StockholmHealthcarePharmaceuticalsSEK 109.56B50.2x-1.33SEK 319.200.4%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+3.8% UpsideUpgrade to Pro+
StockholmHealthcarePharmaceuticalsSEK 34.49B148x-3.72SEK 588.50-9.8%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+15.9% UpsideUpgrade to Pro+
StockholmHealthcarePharmaceuticalsSEK 21.84B179.8x1.22SEK 41.60-0.4%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+20.4% UpsideUpgrade to Pro+
StockholmHealthcarePharmaceuticalsSEK 21.81B74.7x0.07SEK 330-3.7%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+-0.8% DownsideUpgrade to Pro+
StockholmHealthcarePharmaceuticalsSEK 9.88B24.6x-7.71SEK 98-2.6%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+49.1% UpsideUpgrade to Pro+
StockholmHealthcarePharmaceuticalsSEK 6.36B84.1x1.97SEK 40.160.9%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+48.2% UpsideUpgrade to Pro+
StockholmHealthcarePharmaceuticalsSEK 3.55B-421.6xSEK 45.481.5%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+51.8% UpsideUpgrade to Pro+
StockholmHealthcarePharmaceuticalsSEK 3B219.2x-7.39SEK 263-1.5%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+
StockholmHealthcarePharmaceuticalsSEK 639.60M-18.5x-0.32SEK 3.9815.4%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+
StockholmHealthcarePharmaceuticalsSEK 633.03M62.3x-6.46SEK 33-4.1%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+45.3% UpsideUpgrade to Pro+
StockholmHealthcarePharmaceuticalsSEK 617.23M-5.2x-0.21SEK 11.90-2.5%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+244.3% UpsideUpgrade to Pro+
StockholmHealthcarePharmaceuticalsSEK 501.02M-11.9x-0.49SEK 10.710.3%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+77.9% UpsideUpgrade to Pro+
StockholmHealthcarePharmaceuticalsSEK 465.81M-4.8x-0.1SEK 13.50-0.2%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+55.6% UpsideUpgrade to Pro+
StockholmHealthcarePharmaceuticalsSEK 463.42M-3.3x0.17SEK 34.80-0.9%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+
SpotlightHealthcarePharmaceuticalsSEK 402.90M-4.4x0.09SEK 23.411.3%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+
StockholmHealthcarePharmaceuticalsSEK 327.69M-5.7x-0.46SEK 1.89-0.5%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+117.7% UpsideUpgrade to Pro+
StockholmHealthcarePharmaceuticalsSEK 299.10M-3.2x-0.18SEK 14.402.1%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+6.4% UpsideUpgrade to Pro+
StockholmHealthcarePharmaceuticalsSEK 237.06M-3.9x-0.09SEK 3.92-2%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+
StockholmHealthcarePharmaceuticalsSEK 164.19M-25.5x0.03SEK 7.64-0.5%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+225.5% UpsideUpgrade to Pro+
StockholmHealthcarePharmaceuticalsSEK 138.89M-15.1x-0.29SEK 4.94-3.5%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+
StockholmHealthcarePharmaceuticalsSEK 137.74M-1.4x-0.02SEK 0.260%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+66% UpsideUpgrade to Pro+
SpotlightHealthcarePharmaceuticalsSEK 132.94M-2.8x-0.06SEK 0.176.3%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+
StockholmHealthcarePharmaceuticalsSEK 118.30M-5.4x-0.33SEK 10.463.6%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+-90.6% DownsideUpgrade to Pro+
StockholmHealthcarePharmaceuticalsSEK 116.72M-0.4x-0.15SEK 0.14-2.1%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+
SpotlightHealthcarePharmaceuticalsSEK 116.27M-13.5x0.27SEK 8.420%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+
StockholmHealthcarePharmaceuticalsSEK 71.92M-0.9x-0.02SEK 0.86-2%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+
StockholmHealthcarePharmaceuticalsSEK 52.99M-2x-1.34SEK 1.541.7%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+58.9% UpsideUpgrade to Pro+
SpotlightHealthcarePharmaceuticalsSEK 48.70M226.6x1.3SEK 3.18-0.6%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+
StockholmHealthcarePharmaceuticalsSEK 36.39M-2.5x-0.19SEK 2.300.9%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+
  • 1
  • 2
  • 30 Rows
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.